Revenue of $6.7 Million Reflects 1,027% Year-Over-Year Growth; Fourth Consecutive Record-Setting Quarter SAN DIEGO, Nov. 11, 2025 (GLOBE NEWSWIRE) — NeoVolta Inc. (NASDAQ: NEOV), a U.S.-based energy technology company delivering scalable storage, for resilient residential and commercial power infrastructure, today announced financial results for its first quarter of fiscal 2026, which ended September 30, 2025. “Our first quarter performance demonstrates the strength of our multi-channel growth strategy and the increasing market adoption of distributed energy storage solutions,” said Ardes Johnson, Chief Executive Officer of NeoVolta. “We delivered $6.7 million in revenue, representing over 1,000% year-over-year growth and marking our fourth consecutive record quarter. This momentum reflects successful expansion...

Third Quarter 2025 Net Loss of $875,000 ($0.26 loss per share) v. Net Income of 558,000 ($0.17 per diluted share) in Prior Year Period Third Quarter 2025 EBITDA, As Adjusted, was a loss of $508,000 ($0.15 loss per share) v. Earnings of $749,000 ($0.22 per diluted share) in Prior Year Period Nine Months 2025 Net Loss of $4,317,000 ($1.30 loss per share) v. Net Loss of $394,000 ($0.12 loss per share) in Prior Year Period. Nine Months 2025 EBITDA, As Adjusted, was a loss of $3,506,000 ($1.05 loss per share) v. a loss of $199,000 ($0.06 loss per share) in Prior Year Period. Backlog at September 30, 2025 was $12.7 million compared to $12.0 million at December 31, 2024 Supply Chain Issue at Orbit Power Group (“OPG”) Prevents Return to EBITDA, As Adjusted Profitability for Current Third Quarter HAUPPAUGE, N.Y., Nov. 11, 2025 (GLOBE NEWSWIRE)...

LOS ANGELES, Nov. 11, 2025 (GLOBE NEWSWIRE) — PodcastOne (Nasdaq: PODC), a leading publisher and podcast sales network, today announced record financial results for the second quarter (“Q2 Fiscal 2026”) and first half (“1H Fiscal 2026”) of its fiscal year ending March 31, 2026. Financial Highlights:Q2 Fiscal 2026Revenue: $15.2 Million, up 22% year-over-year Adjusted EBITDA*: $1.1 Million, up 369% year-over-year1H Fiscal 2026Revenue: $30.2 Million, up 19% year-over-year Adjusted EBITDA*: $1.7 Million, up 332% year-over-yearRaised Fiscal 2026 GuidanceRevenue: $56-60 Million Adjusted EBITDA*: $4.5-6 MillionOperational Highlights:Added 17 new podcasts year-to-date, totaling 210 shows across the network Maintained Top 10 Publisher status in Podtrac rankings for 12 consecutive months (currently #9) Achieved record...

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION INTHE UNITED STATES OR TO U.S. NEWS AGENCIES HONG KONG, Nov. 11, 2025 (GLOBE NEWSWIRE) — Century Global Commodities Corporation (“Century” or the “Company”) (TSX: CNT) is pleased to announce that it has filed its condensed consolidated interim financial statements for the second fiscal quarter ended September 30, 2025 and the related management discussion and analysis (“MD&A”). Copies of these documents are available under Century’s SEDAR+ profile at http://www.sedarplus.ca and will also be posted on Century’s website at www.centuryglobal.ca. As of September 30, 2025, the Company had unrestricted free cash, bank deposits and marketable securities totaling $3.4 million (March 31, 2025: $4.2 million) and a net working capital* of $5.6 million (March 31, 2025: $6.0 million), which is...

Revenue increased 29% to $13.5 million in Q3 2025 as compared with Q3 2024 Operating income totaled $1.3 million and Adjusted EBITDA rose approximately 80% to $2.0 million in Q3 2025, as compared with Q3 2024 Remaining performance obligations increased to $65 million FDA cleared an accelerated protocol for Deep TMS treatment of patients with major depressive disorder (MDD) Raised midpoint of full-year 2025 Revenue and EBITDA guidance Conference call to be held today at 8:30 AM ET BURLINGTON, Mass. and JERUSALEM, Israel, Nov. 11, 2025 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today reported third quarter 2025 financial results and provided an operational update. Recent Financial and...

VANCOUVER, British Columbia, Nov. 11, 2025 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology business solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS and Quantum Computing solutions, announces financial results for the third quarter ended September 30, 2025, which includes a record 1,225% increase in year-over-year revenue for the quarter. The company achieved a 6X revenue increase for the first nine months of the year with revenue of $7.73 million compared to the same period of 2024 (all figures are in Canadian dollars). These results represent the company’s highest-ever quarterly revenue driven by exceptional performance of the Drone as a Service segment and in addition includes the highest ever quarterly...

Palvella’s recently expanded rare disease pipeline now comprises QTORIN™-derived product candidates advancing in four serious, rare skin diseases that currently have no FDA-approved therapies Top-line results for fully enrolled Phase 2 TOIVA trial evaluating QTORIN™ 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin) for cutaneous venous malformations remain on track for mid-December 2025 Top-line results for fully enrolled Phase 3 SELVA trial evaluating QTORIN™ rapamycin for microcystic lymphatic malformations remain on track for the first quarter of 2026 Expanded QTORIN™ rapamycin’s development into clinically significant angiokeratomas, a rare and debilitating lymphatic disease with no FDA-approved therapies, with Phase 2 study initiation anticipated in second half of 2026 Announced new QTORIN™...

MONTREAL, Nov. 11, 2025 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) today announced third quarter financial and operational results for the three-month period ended September 30, 2025. All amounts are in US dollars, unless otherwise stated. Q3-2025 Highlights OperationalRecord silver production of 1.35 million (“M”) ounces (“oz”) up 278% vs. the prior year driven by the new Zgounder plant; and up 29% increase quarter-over-quarter (“QoQ”), driven by record throughput and improved grades. Ore processed averaged 3,326 tonnes per day (tpd), up 11% QoQ, with high mill availability of 96%. Mill average feed grade of 146 grams per tonne (“g/t”) Ag, showing improvement QoQ driven by higher-grade underground ore. Silver recovery averaged 92.5% in Q3-2025.FinancialRecord...

Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) — Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the third quarter ended September 30, 2025. Recent Highlights and AccomplishmentsContinued strategic transformation to drive future innovation and growth with promotion of Kevin Cureton to President and Chief Executive Officer. Appointed Laura Riffner, a seasoned financial and operations expert, as Chief Financial Officer to lead accounting and finance management and support strategic planning. Yoana Dvorzsak to lead newly unified group that combines Solésence’s research and development, product and component...

Conference call will be held today, Tuesday, November 11 at 9:00 am ET CARMEL, Ind., Nov. 11, 2025 (GLOBE NEWSWIRE) — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced results for the third quarter period ended September 30, 2025. 3Q25 Financial highlightsRevenues increased 22% year over year to $811 thousand in 3Q25 compared to $667 thousand in 3Q24. Operating loss in 3Q25 increased 27% year over year compared to 3Q24 due to increased sales and marketing efforts. Cash balance was $4.4 million as of September 30, 2025. Subsequently, the Company secured an additional $2.8 million through an at-the-market equity offering and warrant exercises in October 2025.Recent...